To pool or not to pool biological samples? This question might pop up in the mind of anyone designing biomarker discovery approaches!

Much debate has been raised on biomarker discovery from clinical cohort studies, since the first experiments linking SNPs to disease phenotypes, to the current and new proteomic and miRNA technologies. The answer to this question strictly depends on clinical data, patient group characteristics and… financial means.